Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Sinco Pharmaceuticals Holdings Ltd. ( (HK:6833) ) has issued an announcement.
Sinco Pharmaceuticals Holdings Limited has proposed a final ordinary cash dividend of HKD 0.167 per share for the financial year ended 31 December 2025, subject to shareholder approval at a meeting scheduled for 15 May 2026. The dividend will be paid in Hong Kong dollars, with the shares trading ex-dividend on 19 May 2026, a record date of 26 May 2026, and payment slated for 4 June 2026.
The announcement underscores the company’s ongoing commitment to returning cash to shareholders and signals management’s confidence in its 2025 financial performance. The clarified timetable for book closure, record date and payment provides investors with visibility on income timing and may support the stock’s appeal to income-focused shareholders in the Hong Kong market.
The most recent analyst rating on (HK:6833) stock is a Sell with a HK$0.16 price target. To see the full list of analyst forecasts on Sinco Pharmaceuticals Holdings Ltd. stock, see the HK:6833 Stock Forecast page.
More about Sinco Pharmaceuticals Holdings Ltd.
Sinco Pharmaceuticals Holdings Limited is a Hong Kong-listed company in the pharmaceuticals sector. The group focuses on the development, production and sale of pharmaceutical products, serving healthcare markets where consistent shareholder returns are supported by its operating performance and cash generation.
Average Trading Volume: 336,088
Technical Sentiment Signal: Sell
Current Market Cap: HK$353.7M
For detailed information about 6833 stock, go to TipRanks’ Stock Analysis page.